ScreenerHero

GLOW Glow Lifetech Corp.

CNQ · CA · Healthcare · Biotechnology · glowlifetech.com
0.0400CAD0.00%Mkt Cap: 5.61M $P/E: —

Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-solubl…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap5.61M USD
Enterprise Value4.47M USD
Revenue (TTM)1.68M USD
Gross Profit992.03K USD
Net Income (TTM)-449.96K USD
Revenue/Share0.01 CAD
Last Price0.0400 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA37989H1091
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-26.54
EV/Revenue2.66
P/S3.34
P/B2.50
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.04000% of range0.0750
52W High0.0750 CAD
52W Low0.0400 CAD
Profitability
Gross Margin66.33%
Oper. Margin-29.29%
EBITDA Margin-10.03%
Profit Margin-30.09%
ROE-22.80%
ROA-15.78%
Growth
Revenue Growth19.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.94K USD
CapEx (TTM)75.14K USD
FCF Margin11.79%
FCF Yield3.53%
Net Debt-1.14M USD
Net Debt/EBITDA6.75
Balance Sheet
Debt/Equity0.02
Current Ratio2.63
Quick Ratio1.93
Book Value/Sh0.02 CAD
Cash/Share0.0080 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.192.44M
Float138.44M
Insiders23.18%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short7.62K
Short (prev mo.)563
Technical
SMA 500.0438 (-8.7%)
SMA 2000.0490 (-18.3%)
Beta1.43
S&P 52W Chg14.58%
Avg Vol (30d)100.00K
Avg Vol (10d)18.01K
Technical Indicators
RSI (14)32.6
MACD-0.0011
MACD Signal-0.0007
MACD Hist.-0.0004
BB Upper0.0482 CAD
BB Middle0.0437 CAD
BB Lower0.0393 CAD
BB Width20.31%
ATR (14)0.0013 CAD
Vol Ratio (20d)2.14x